company

DIN REISEVAKSINE AS

7044 TRONDHEIM

Return on Equity
12,72 %
Current Ratio
2,81
Debt-to-Equity Ratio
0,13
Key figures (NOK)2022
Revenue4 356 000
Net Income99 000
Total Assets1 324 000
Total Equity778 000
Income (NOK)2022
Revenue4 356 000
Expenditure4 259 000
Operating Profit128 000
Financial Income12 000
Financial Costs13 000
Financial Balance−1 000
Earnings Before Tax127 000
Tax28 000
Net Income99 000
Balance (NOK)2022
Total Fixed Assets78 000
Total Current Assets1 246 000
Total Assets1 324 000
Total Retained Equity388 000
Total Equity778 000
Total Long-Term Debt102 000
Total Current Debt443 000
Total Equity and Debt1 324 000
Cash flow (NOK)2022
Sales Income4 349 000
Other Income8 000
Revenue4 356 000
Cost of Goods Sold2 179 000
Salary Costs1 471 000
Depreciation34 000
Impairment0
Expenditure4 259 000
Operating Profit128 000
Financial Income12 000
Financial Costs13 000
Financial Balance−1 000
Dividends0
Net Income99 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets31 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures47 000
Total Tangible Assets47 000
Total Fiancial Fixed Assets0
Total Fixed Assets78 000
Stock179 000
Total Investments0
Cash, Bank693 000
Total Current Assets1 246 000
Total Assets1 324 000
Total Equity778 000
Short-Term Group Debt0
Total Long-Term Debt102 000
Creditors189 000
Unpaid Taxes72 000
Dividends0
Other Current Debt152 000
Total Current Debt443 000
Total Equity and Debt1 324 000
Financial indicators2022
Return on Equity12,72 %
Debt-to-Equity Ratio0,13
Operating Profit Margin2,94 %
Current Ratio2,81
Quick Ratio4,72
Equity Ratio0,59
Gross Profit Margin49,98 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English